קלפורן

Pays: Israël

Langue: hébreu

Source: Ministry of Health

Achète-le

Ingrédients actifs:

CEFOTAXIME AS SODIUM 1 G

Disponible depuis:

SANOFI - AVENTIS ISRAEL LTD

Code ATC:

J01DD01

forme pharmaceutique:

POWDER FOR SOLUTION FOR INJ/INF

Mode d'administration:

I.M, I.V

Fabriqué par:

PATHEON UK LIMITED, UK

Groupe thérapeutique:

CEFOTAXIME

indications thérapeutiques:

Severe infections caused by cefotaxime - sensitive pathogens : Infections of the respiratory tract of the kidneys and urinary tract of the skin and soft tissues of the bones and joints of the genital organs including gonorrhoea and of the abdominal region. Sepsis endocarditis meningitis. For preoperative prophylaxis in patients who are at increased risk from infection. For the prophylaxis of infections in patients with reduced resistance.

Date de l'autorisation:

2012-11-01

Rechercher des alertes liées à ce produit

Afficher l'historique des documents